AORT - Artivion Inc logo

Artivion Inc

AORT

Artivion Inc. manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgeries, focusing on aortic diseases. Key products include heart valves, stent grafts, and surgical sealants, primarily sold to healthcare facilities.

โš•๏ธ Healthcare NYSE Listed 1993 $ USD
$1,000 invested 30 years ago โ†’$2,888today

Score Overview

1 Year
Score
Net Growth-132.40%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth6.83%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.9
Net Growth78.66%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth57.77%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth-129.37%
Net Trend40%
Net Income Consistency
Rev Growth161.38%
Rev Trend90%
Revenue Consistency
20 Years
Score4.2
Net Growth-8x
Net Trend50%
Net Income Consistency
Rev Growth479.84%
Rev Trend95%
Revenue Consistency
30 Years
Score
Net Growth-181.15%
Net Trend53%
Net Income Consistency
Rev Growth12x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-5x
Net Trend58%
Net Income Consistency
Rev Growth22x
Rev Trend91%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Artivion Inc has ranked, year by year

Measure
Fundamentals Window

Showing 1 year ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • AORT

1998: 45.3% ยท 2021: 91.3% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 22.95โ€”
1 Year2025-09-26
$ 41.06-44.11%
5 Years2021-09-28
$ 22.96-0.04%
10 Years2016-09-28
$ 17.8428.64%
20 Years2006-09-28
$ 6.24268.02%
30 Years1996-09-27
$ 7.95188.82%
All Time1993-02-12
$ 3.816x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 471M-$ 3M$ 77M
2025$ 441M$ 9M$ 64M
2024$ 388M-$ 13M$ 53M
2023$ 354M-$ 30M$ 58M
2022$ 313M-$ 19M$ 39M
2021$ 298M-$ 14M$ 55M
2020$ 253M-$ 16M$ 61M
2019$ 276M$ 1M$ 33M
2018$ 262M-$ 3M$ 41M
2017$ 189M$ 3M$ 40M
2016$ 180M$ 10M$ 57M
2015$ 145M$ 4M$ 43M
2014$ 144M$ 7M$ 33M
2013$ 140M$ 16M$ 42M
2012$ 131M$ 7M$ 18M
2011$ 119M$ 7M$ 21M
2010$ 116M$ 3M$ 35M
2009$ 111M$ 8M$ 30M
2008$ 105M$ 32M$ 17M
2007$ 94M$ 7M$ 17M
2006$ 81M$ 365K$ 8M
2005$ 69M-$ 19M$ 11M
2004$ 62M-$ 18M$ 8M
2003$ 59M-$ 32M$ 10M
2002$ 77M-$ 27M$ 24M
2001$ 87M$ 9M$ 33M
2000$ 77M$ 7M$ 38M
1999$ 66M$ 4M$ 30M
1998$ 60M$ 6M$ 12M
1997$ 50M$ 4M$ 100K
1996$ 37M$ 3M$ 1M
1995$ 29M$ 2M$ 200K
1994$ 23M$ 1M$ 2M
IPO1993$ 21M$ 600K$ 1M
AORT - Artivion Inc logo

Artivion Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 253M to $ 441M and net income went from -$ 16M to $ 9M. Revenue increased in every one of those 5 years; net income in 2.

Across Artivion Inc's full reported history, from 1993 to 2025, revenue grew from $ 21M to $ 441M and net income grew from $ 600K to $ 9M. Revenue increased in 91% of the years measured; net income in 58%.

Artivion Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.

Membership

Continue AORTโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies